PRIYA KARMALI

Chief Technology Officer Capstan Therapeutics

Priya Karmali, Ph.D., is Chief Technology Officer at Capstan Therapeutics and leads all aspects of technology development for Capstan’s targeted lipid nanoparticle technology platform. Karmali has over 20 years of experience in the field of lipid nanoparticle delivered RNA therapeutics and has led development of multiple RNA therapeutics and vaccines currently in various phases of clinical trials. Previously Vice President of Technology Innovation and Development at Arcturus Therapeutics, Karmali also worked at Regulus Therapeutics and Nitto Denko.

Karmali has a Ph.D. in Chemistry from Indian Institute of Chemical Technology where her doctoral research was focused on development of novel liposomal nucleic acid delivery systems for use in nonviral gene therapy and DNA vaccination. She pursued her postdoctoral research at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, focusing on developing targeted nanoparticles for drug delivery. Karmali is an author and co-inventor on over 70 scientific publications and patents in the field.